Nomogram for predicting recurrence in stage II colorectal cancer
- 1 September 2016
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 55 (12) , 1414-1417
Abstract
Background: There have been no established criteria to distinguish patients at high and low risk of recurrence in stage II colorectal cancer. Several risk factors have been identified but recurrence could not be fully predicted by each factor alone. This retrospective study sought to develop a nomogram for accurate prediction of recurrence in stage II colorectal cancer. Material and methods: We reviewed the data for 4167 patients with stage II colorectal cancer who underwent surgery between January 1997 and December 2006. The risk factors for recurrence were identified, and a nomogram for recurrence was created using the factors. The performance of the nomogram was assessed with a bootstrapped-concordance index and calibration plots. Results: Sex, carcinoembryonic antigen, tumor location, tumor depth, lymphatic invasion, venous invasion and number of lymph nodes studied were significantly associated with recurrence. A nomogram for five-year freedom from recurrence was created with these factors. The bootstrapped-concordance index of the nomogram was 0.64, and it was well calibrated. Conclusions: Our nomogram can be a useful tool for accurate prediction of recurrence in stage II colorectal cancer.Keywords
This publication has 24 references indexed in Scilit:
- Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon CancerAnnals of Surgery, 2013
- Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer TrialJournal of Clinical Oncology, 2012
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancerInternational Journal of Clinical Oncology, 2011
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Long-Term Survival Results of Surgery Alone Versus Surgery Plus 5-Fluorouracil and Leucovorin for Stage II and Stage III Colon Cancer: Pooled Analysis of NSABP C-01 Through C-05. A Baseline from Which to Compare Modern Adjuvant TrialsAnnals of Surgical Oncology, 2010
- A Nomogram for Predicting Disease-specific Survival After Hepatic Resection for Metastatic Colorectal CancerAnnals of Surgery, 2008
- Individualized Prediction of Colon Cancer Recurrence Using a NomogramJournal of Clinical Oncology, 2008
- Randomised trials of HIV preventionThe Lancet, 2007
- American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon CancerJournal of Clinical Oncology, 2004
- Adjuvant chemotherapy for stage II colon cancer:the time has comeEuropean Journal of Surgical Oncology, 2000